Biomea Fusion, Inc.
BMEA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840439
No open-market purchases or sales by Biomea Fusion, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Biomea Fusion, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 39 | 49 | +10 |
| Shares | 17.1M | 17.1M | −13.7K (−0.1%) |
| Value | $204.5M | $127.3M | −$77.3M (−37.8%) |
New holders (12)
Institutions that held Biomea Fusion, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DAFNA Capital Management LLC | 313,923 | $2.34M | 0.59% |
| Millennium Management LLC | 103,244 | $769.0K | 0.00% |
| Citadel Advisors LLC | 43,604 | $325.0K | 0.00% |
| Qube Research & Technologies Ltd | 31,388 | $234.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 20,955 | $156.0K | 0.00% |
| Goldman Sachs Group Inc | 19,934 | $149.0K | 0.00% |
| Renaissance Technologies LLC | 17,100 | $127.0K | 0.00% |
| Two Sigma Investments, LP | 17,010 | $127.0K | 0.00% |
| Jump Financial, LLC | 16,500 | $123.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 14,978 | $112.0K | 0.00% |
| Wells Fargo & Company | 11,880 | $88.0K | 0.00% |
| Point72 Hong Kong Ltd | 1,869 | $14.0K | 0.00% |
Sold out (2)
Institutions that held Biomea Fusion, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Invesco Ltd. | 205,120 | $2.46M |
| Evolution Wealth Advisors, LLC | 319 | $4.00K |